These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Clinical pharmacokinetics of drugs for Alzheimer's disease. Parnetti L Clin Pharmacokinet; 1995 Aug; 29(2):110-29. PubMed ID: 7586900 [TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of aniracetam and its metabolites in rat brain. Ogiso T; Uchiyama K; Suzuki H; Yoshimoro M; Tanino T; Iwakai M; Uno S Biol Pharm Bull; 2000 Apr; 23(4):482-6. PubMed ID: 10784432 [TBL] [Abstract][Full Text] [Related]
7. [Strategy for the development of dipeptide drugs]. Gudasheva TA Vestn Ross Akad Med Nauk; 2011; (7):8-16. PubMed ID: 21899085 [TBL] [Abstract][Full Text] [Related]
8. [The role of non-NMDA glutamate receptors in the EEG effects of chronic administration of noopept GVS-111 in awake rats]. Kovalev GI; Vorob'ev VV Eksp Klin Farmakol; 2002; 65(6):6-9. PubMed ID: 12596524 [TBL] [Abstract][Full Text] [Related]
9. [Pharmacokinetic properties of an innovative nootropic agent based on a derivative of 3,7-diazabicyclo[3.3.1]nonane]. Brkich GE; Pyatigorskaya NV; Beregovykh VV; Nedorubov AA; Filippova OV; Zyryanov OA Biomed Khim; 2020 Jan; 66(1):71-76. PubMed ID: 32116228 [TBL] [Abstract][Full Text] [Related]
15. [The effect of the new nootropic dipeptide GVS-111 in different functional disorders of the escape reaction]. Inozemtsev AN; Trofimov SS; Borlikova GG; Firova FA; Pragina LL; Gudasheva TA; Ostrovskaia RU; Tushmalova NA; Voronina TA Eksp Klin Farmakol; 1998; 61(3):10-2. PubMed ID: 9690067 [TBL] [Abstract][Full Text] [Related]
16. [Comparative study of permeability of derivatives of gamma-aminobutyric and gamma-hydroxybutyric acids through hemato-encephalic barrier]. Nasybullina NM; Zherdev VP; Gunar VI; Kopelevich VM; Kozlova GS Eksp Klin Farmakol; 1997; 60(6):52-4. PubMed ID: 9460601 [TBL] [Abstract][Full Text] [Related]
17. Matrix-assisted laser desorption/ionization imaging mass spectrometry of intraperitoneally injected danegaptide (ZP1609) for treatment of stroke-reperfusion injury in mice. Wang JSH; Freitas-Andrade M; Bechberger JF; Naus CC; Yeung KK; Whitehead SN Rapid Commun Mass Spectrom; 2018 Jun; 32(12):951-958. PubMed ID: 29575411 [TBL] [Abstract][Full Text] [Related]
18. Neuroprotective properties of nootropic dipeptide GVS-111 in in vitro oxygen-glucose deprivation, glutamate toxicity and oxidative stress. Andreeva NA; Stel'mashuk EV; Isaev NK; Ostrovskaya RU; Gudasheva TA; Viktorov IV Bull Exp Biol Med; 2000 Oct; 130(10):969-72. PubMed ID: 11177296 [TBL] [Abstract][Full Text] [Related]
19. Nootropics: pharmacological properties and therapeutic use. Gabryel B; Trzeciak HI Pol J Pharmacol; 1994; 46(5):383-94. PubMed ID: 7894524 [TBL] [Abstract][Full Text] [Related]
20. [The use of the HPLC method for the quantitative determination of a peptide analog of piracetam with nootropic activity and its main metabolites]. Boĭko SS; Zherdev VP; Gudasheva TA; Vasilevich NI; Ostrovskaia RU; Voronina TA; Rozantsev GG Eksp Klin Farmakol; 1996; 59(2):38-40. PubMed ID: 8974563 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]